Sep 14, 2026
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.35 to $0.02.
The split itself did not change the total investment value.
NeuroSense Therapeutics Ltd. (NRSN) trades on the NASDAQ Capital Market in the Biotechnology industry.
NeuroSense Therapeutics Ltd. company overviewThe latest split shown was on September 14, 2026. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records one reverse split, on September 14, 2026.
Already premium? Sign in